Literature DB >> 15734666

Bilateral subthalamic nucleus stimulation improves health-related quality of life in Parkinsonian patients.

Tuomo Erola1, Petri Karinen, Esa Heikkinen, Juho Tuominen, Tarja Haapaniemi, John Koivukangas, Vilho Myllylä.   

Abstract

Parkinson's disease (PD) is a common neurological disorder. Recently, bilateral deep brain stimulation (DBS) of the subthalamic nucleus (STN) has become an option in the treatment of severe PD. We measured the health-related quality of life (HRQoL) of 27 parkinsonian patients, who underwent a bilateral STN-operation. The instruments used for the evaluation of the HRQoL were the Parkinson's Disease Questionnaire (PDQ-39) and the Finnish version of the Nottingham Health Profile (NHP). We found that the quality of life significantly improved when measured with both HRQoL scales. Clinical improvement and improvement in HRQoL were positively correlated.

Entities:  

Mesh:

Year:  2005        PMID: 15734666     DOI: 10.1016/j.parkreldis.2004.08.006

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  13 in total

1.  Axial rigidity and quality of life in patients with Parkinson's disease: a preliminary study.

Authors:  Roberto Cano-de-la-Cuerda; Lydia Vela-Desojo; Juan Carlos Miangolarra-Page; Yolanda Macías-Macías; Elena Muñoz-Hellín
Journal:  Qual Life Res       Date:  2010-12-14       Impact factor: 4.147

Review 2.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

3.  Bilateral subthalamic stimulation impairs cognitive-motor performance in Parkinson's disease patients.

Authors:  Jay L Alberts; Claudia Voelcker-Rehage; Katie Hallahan; Megan Vitek; Rashi Bamzai; Jerrold L Vitek
Journal:  Brain       Date:  2008-10-07       Impact factor: 13.501

Review 4.  A review of the health-related quality of life and economic impact of Parkinson's disease.

Authors:  Clare H Dowding; Claire L Shenton; Sam S Salek
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

5.  The spectrum of responsibility ascription for end users of neurotechnologies.

Authors:  Andreas Schönau
Journal:  Neuroethics       Date:  2021-02-28       Impact factor: 1.480

Review 6.  The effect of deep brain stimulation on quality of life in movement disorders.

Authors:  A Diamond; J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

7.  Stimulation-Induced Transient Nonmotor Psychiatric Symptoms following Subthalamic Deep Brain Stimulation in Patients with Parkinson's Disease: Association with Clinical Outcomes and Neuroanatomical Correlates.

Authors:  Osama A Abulseoud; Aimen Kasasbeh; Hoon-Ki Min; Julie A Fields; Susannah J Tye; Stephan Goerss; Emily J Knight; Shirlene M Sampson; Bryan T Klassen; Joseph Y Matsumoto; Cynthia Stoppel; Kendall H Lee; Mark A Frye
Journal:  Stereotact Funct Neurosurg       Date:  2016-04-20       Impact factor: 1.875

8.  Factors related to outcomes of subthalamic deep brain stimulation in Parkinson's disease.

Authors:  Hae Yu Kim; Won Seok Chang; Dong Wan Kang; Young Ho Sohn; Myung Sik Lee; Jin Woo Chang
Journal:  J Korean Neurosurg Soc       Date:  2013-08-31

Review 9.  Neurosurgery in Parkinson's disease: Social adjustment, quality of life and coping strategies.

Authors:  Meyer Mylène; Montel Sébastien; Colnat-Coulbois Sophie; Lerond Jérôme; Potheegadoo Jevita; Vidailhet Pierre; Gospodaru Nicolaie; Vespignani Hervé; Barroche Gérard; Spitz Elisabeth; Schwan Raymund
Journal:  Neural Regen Res       Date:  2013-10-25       Impact factor: 5.135

10.  Neuropsychological and quality of life assessment in patients with Parkinson's disease submitted to bilateral deep brain stimulation in the subthalamic nucleus.

Authors:  Alessandra Shenandoa Heluani; Fábio Henrique de Gobbi Porto; Sergio Listik; Alexandre Walter de Campos; Alexandre Aluizio Costa Machado; Arthur Cukiert; José Oswaldo de Oliveira
Journal:  Dement Neuropsychol       Date:  2012 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.